New ideas for the treatment of neovascular glaucoma
Ruiling Zhao, Feng Gao, Douhong Liu
Abstract
Ruiling Zhao, Feng Gao, Douhong Liu
Abstract
Objective To observe the efficacy of intravitreal injection of Lucentis, excessive pressure regulation system (EX-press)implantation and panretinal photocoagulation for neovascular glaucoma(NVG). Methods The data of 38 eyes of 38 cases with NVG from Jan.2015 to May 2016 were analyzed retrospectively. Intravitreal injection of Lucentis was performed for all cases at first. EX-press implantation was performed 3-5 days after new vessels of iris disappeared. All cases received panretinal photocoagulation under indirect ophthalmoscope 5-7 days after EX-press implantation. The BCVA and IOP were observed and recorded. Results After 1 year of follow-up, IOP within 10-15 mmHg was in 9 cases and within 16-21 mmHg was in 29 cases (1 mmHg=0.133 kPa). Among 29 cases, 4 cases combined with Carteolol hydrochloride eye drops. Conclusion Intravitreal injection of Lucentis, EX-press implantation, combined with panretinal photocoagulation is a safe and effective method for NVG. Key words: Glaucoma, neovascular; Implantaion, Ex-press; Photocoagulation, panretinal
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the efficacy of intravitreal injection of Lucentis, excessive pressure regulation system (EX-press)implantation and panretinal photocoagulation for neovascular glaucoma(NVG). Methods The data of 38 eyes of 38 cases with NVG from Jan.2015 to May 2016 were analyzed retrospectively. Intravitreal injection of Lucentis was performed for all cases at first. EX-press implantation was performed 3-5 days after new vessels of iris disappeared. All cases received panretinal photocoagulation under indirect ophthalmoscope 5-7 days after EX-press implantation. The BCVA and IOP were observed and recorded. Results After 1 year of follow-up, IOP within 10-15 mmHg was in 9 cases and within 16-21 mmHg was in 29 cases (1 mmHg=0.133 kPa). Among 29 cases, 4 cases combined with Carteolol hydrochloride eye drops. Conclusion Intravitreal injection of Lucentis, EX-press implantation, combined with panretinal photocoagulation is a safe and effective method for NVG. Key words: Glaucoma, neovascular; Implantaion, Ex-press; Photocoagulation, panretinal
Key concepts: Panretinal photocoagulation, Neovascular glaucoma, Medicine, Ophthalmology, Glaucoma, Intraocular pressure, Diabetic retinopathy, Diabetes mellitus